 Muhammad Aftab
Concepts (299)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aorta, Thoracic | 20 | 2025 | 286 | 3.920 |
Why?
| | Aortic Aneurysm, Thoracic | 14 | 2022 | 139 | 3.190 |
Why?
| | Cardiac Surgical Procedures | 14 | 2023 | 609 | 3.030 |
Why?
| | Blood Vessel Prosthesis Implantation | 12 | 2024 | 228 | 2.310 |
Why?
| | Postoperative Complications | 15 | 2025 | 2920 | 2.080 |
Why?
| | Aortic Aneurysm | 5 | 2020 | 70 | 1.770 |
Why?
| | Hospital Mortality | 14 | 2025 | 1031 | 1.700 |
Why?
| | Cardiopulmonary Bypass | 6 | 2020 | 221 | 1.650 |
Why?
| | Circulatory Arrest, Deep Hypothermia Induced | 4 | 2022 | 26 | 1.370 |
Why?
| | Spinal Cord Ischemia | 9 | 2025 | 60 | 1.360 |
Why?
| | Endovascular Procedures | 8 | 2025 | 384 | 1.250 |
Why?
| | Loeys-Dietz Syndrome | 2 | 2019 | 6 | 1.150 |
Why?
| | Spinal Cord | 7 | 2025 | 382 | 1.120 |
Why?
| | Vascular Surgical Procedures | 5 | 2025 | 340 | 1.090 |
Why?
| | Thrombocytopenia | 2 | 2020 | 205 | 1.080 |
Why?
| | Aortic Valve | 8 | 2020 | 365 | 0.990 |
Why?
| | Acute Kidney Injury | 5 | 2025 | 866 | 0.990 |
Why?
| | Heart Valve Prosthesis Implantation | 4 | 2017 | 197 | 0.980 |
Why?
| | Aorta | 8 | 2025 | 430 | 0.950 |
Why?
| | Paraplegia | 5 | 2022 | 61 | 0.890 |
Why?
| | Heart Transplantation | 6 | 2023 | 736 | 0.870 |
Why?
| | Heart Valve Diseases | 4 | 2020 | 151 | 0.860 |
Why?
| | Thoracic Surgery | 8 | 2020 | 144 | 0.840 |
Why?
| | Extracorporeal Membrane Oxygenation | 4 | 2025 | 383 | 0.810 |
Why?
| | Spinal Cord Injuries | 4 | 2021 | 241 | 0.810 |
Why?
| | Intraoperative Neurophysiological Monitoring | 2 | 2021 | 32 | 0.780 |
Why?
| | Shock, Cardiogenic | 2 | 2020 | 64 | 0.730 |
Why?
| | Dissection | 3 | 2020 | 56 | 0.690 |
Why?
| | Coronary Artery Disease | 5 | 2026 | 741 | 0.640 |
Why?
| | Diazoxide | 5 | 2021 | 21 | 0.630 |
Why?
| | Coronary Artery Bypass | 4 | 2026 | 269 | 0.610 |
Why?
| | Blood Transfusion | 2 | 2020 | 405 | 0.610 |
Why?
| | Kidney Failure, Chronic | 3 | 2025 | 598 | 0.610 |
Why?
| | Aortitis | 1 | 2019 | 10 | 0.600 |
Why?
| | Spinal Cord Stimulation | 1 | 2019 | 8 | 0.590 |
Why?
| | Politics | 1 | 2020 | 97 | 0.590 |
Why?
| | Creatinine | 2 | 2020 | 506 | 0.580 |
Why?
| | Humans | 76 | 2026 | 144957 | 0.580 |
Why?
| | Reperfusion Injury | 4 | 2025 | 300 | 0.570 |
Why?
| | Aortic Valve Insufficiency | 1 | 2018 | 43 | 0.560 |
Why?
| | Perfusion | 3 | 2022 | 250 | 0.560 |
Why?
| | Middle Aged | 34 | 2026 | 35928 | 0.540 |
Why?
| | Length of Stay | 7 | 2025 | 1337 | 0.540 |
Why?
| | Ochronosis | 1 | 2017 | 1 | 0.530 |
Why?
| | Alkaptonuria | 1 | 2017 | 2 | 0.530 |
Why?
| | Erythropoietin | 4 | 2018 | 100 | 0.520 |
Why?
| | Stroke | 4 | 2024 | 1258 | 0.520 |
Why?
| | Retrospective Studies | 26 | 2026 | 17101 | 0.500 |
Why?
| | Oral Submucous Fibrosis | 1 | 2016 | 2 | 0.480 |
Why?
| | Treatment Outcome | 19 | 2025 | 11695 | 0.480 |
Why?
| | Intraoperative Complications | 1 | 2017 | 156 | 0.470 |
Why?
| | Aged | 26 | 2026 | 25947 | 0.470 |
Why?
| | Heart Diseases | 1 | 2019 | 350 | 0.460 |
Why?
| | Mouth Mucosa | 1 | 2016 | 88 | 0.460 |
Why?
| | Cardiomyopathies | 1 | 2019 | 338 | 0.450 |
Why?
| | Male | 47 | 2026 | 72406 | 0.440 |
Why?
| | Aortic Rupture | 1 | 2014 | 28 | 0.430 |
Why?
| | Viscera | 1 | 2014 | 17 | 0.430 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 439 | 0.420 |
Why?
| | Career Choice | 5 | 2016 | 237 | 0.420 |
Why?
| | Aortic Valve Stenosis | 1 | 2017 | 253 | 0.420 |
Why?
| | Risk Assessment | 10 | 2024 | 3676 | 0.410 |
Why?
| | Internship and Residency | 7 | 2020 | 1257 | 0.400 |
Why?
| | Time Factors | 12 | 2026 | 7183 | 0.400 |
Why?
| | Ischemia | 3 | 2021 | 421 | 0.400 |
Why?
| | Prognosis | 7 | 2020 | 4293 | 0.380 |
Why?
| | Female | 39 | 2026 | 78376 | 0.380 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 338 | 0.380 |
Why?
| | Incidence | 4 | 2020 | 2883 | 0.360 |
Why?
| | Cardiovascular Diseases | 2 | 2023 | 2171 | 0.340 |
Why?
| | Neuroprotective Agents | 2 | 2025 | 143 | 0.330 |
Why?
| | Risk Factors | 13 | 2026 | 10792 | 0.330 |
Why?
| | Patient Selection | 4 | 2019 | 719 | 0.320 |
Why?
| | Neurons | 2 | 2020 | 1642 | 0.290 |
Why?
| | Hypothermia, Induced | 2 | 2022 | 96 | 0.290 |
Why?
| | Propensity Score | 3 | 2019 | 367 | 0.280 |
Why?
| | Receptors, Erythropoietin | 2 | 2018 | 21 | 0.280 |
Why?
| | Heart-Assist Devices | 3 | 2019 | 567 | 0.250 |
Why?
| | Cerebrovascular Circulation | 3 | 2022 | 280 | 0.250 |
Why?
| | Comorbidity | 3 | 2020 | 1660 | 0.250 |
Why?
| | Kidney | 1 | 2014 | 1496 | 0.240 |
Why?
| | Aortic Diseases | 2 | 2019 | 124 | 0.240 |
Why?
| | Multivariate Analysis | 3 | 2020 | 1540 | 0.230 |
Why?
| | Adult | 22 | 2025 | 40506 | 0.230 |
Why?
| | Hospitals, Community | 1 | 2025 | 65 | 0.220 |
Why?
| | Specialties, Surgical | 2 | 2016 | 82 | 0.220 |
Why?
| | Neuromuscular Blocking Agents | 1 | 2025 | 26 | 0.220 |
Why?
| | Reoperation | 3 | 2018 | 631 | 0.220 |
Why?
| | Follow-Up Studies | 5 | 2026 | 5417 | 0.210 |
Why?
| | Kaplan-Meier Estimate | 5 | 2019 | 966 | 0.210 |
Why?
| | Survival Rate | 5 | 2026 | 2092 | 0.210 |
Why?
| | Organ Preservation Solutions | 1 | 2023 | 47 | 0.200 |
Why?
| | Intensive Care Units | 2 | 2020 | 916 | 0.200 |
Why?
| | Community Health Services | 1 | 2025 | 234 | 0.200 |
Why?
| | Primary Graft Dysfunction | 1 | 2023 | 35 | 0.200 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2025 | 152 | 0.200 |
Why?
| | Elective Surgical Procedures | 1 | 2025 | 201 | 0.200 |
Why?
| | Anastomosis, Surgical | 3 | 2019 | 157 | 0.190 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2025 | 196 | 0.190 |
Why?
| | Age Factors | 3 | 2020 | 3335 | 0.180 |
Why?
| | Mice, Inbred C57BL | 7 | 2025 | 5997 | 0.170 |
Why?
| | Replantation | 2 | 2018 | 32 | 0.170 |
Why?
| | Heart Valve Prosthesis | 1 | 2023 | 134 | 0.170 |
Why?
| | Databases, Factual | 3 | 2025 | 1486 | 0.170 |
Why?
| | Tissue and Organ Procurement | 2 | 2022 | 346 | 0.160 |
Why?
| | Stents | 3 | 2022 | 556 | 0.160 |
Why?
| | Vascular Grafting | 1 | 2020 | 15 | 0.160 |
Why?
| | Heart Failure | 3 | 2019 | 2323 | 0.160 |
Why?
| | Heart Arrest, Induced | 2 | 2017 | 34 | 0.160 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2019 | 192 | 0.160 |
Why?
| | Education, Medical, Graduate | 2 | 2016 | 557 | 0.160 |
Why?
| | Surgeons | 2 | 2023 | 340 | 0.160 |
Why?
| | United States | 9 | 2025 | 15988 | 0.160 |
Why?
| | Cardiovascular Abnormalities | 1 | 2020 | 15 | 0.160 |
Why?
| | Subclavian Artery | 1 | 2020 | 28 | 0.160 |
Why?
| | Surveys and Questionnaires | 7 | 2020 | 6053 | 0.160 |
Why?
| | Carotid Artery, Common | 1 | 2020 | 31 | 0.160 |
Why?
| | Beauty | 1 | 2020 | 19 | 0.160 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2020 | 48 | 0.160 |
Why?
| | Decision Support Techniques | 1 | 2024 | 456 | 0.150 |
Why?
| | Mitral Valve | 1 | 2020 | 96 | 0.150 |
Why?
| | Acidosis | 1 | 2020 | 105 | 0.150 |
Why?
| | Marfan Syndrome | 2 | 2017 | 46 | 0.150 |
Why?
| | Prosthesis Failure | 1 | 2020 | 128 | 0.150 |
Why?
| | Prosthesis-Related Infections | 1 | 2020 | 99 | 0.150 |
Why?
| | Protein Kinase Inhibitors | 1 | 2025 | 970 | 0.140 |
Why?
| | Morbidity | 1 | 2020 | 323 | 0.140 |
Why?
| | Postoperative Period | 1 | 2020 | 354 | 0.140 |
Why?
| | Age Distribution | 1 | 2019 | 403 | 0.140 |
Why?
| | Mice | 10 | 2025 | 18365 | 0.140 |
Why?
| | Critical Care | 1 | 2025 | 697 | 0.140 |
Why?
| | Sex Distribution | 1 | 2019 | 386 | 0.140 |
Why?
| | Sepsis | 1 | 2025 | 641 | 0.140 |
Why?
| | Early Diagnosis | 1 | 2020 | 249 | 0.140 |
Why?
| | Device Removal | 1 | 2020 | 143 | 0.140 |
Why?
| | Reimbursement Mechanisms | 1 | 2019 | 80 | 0.140 |
Why?
| | Thrombectomy | 1 | 2019 | 78 | 0.140 |
Why?
| | Acute Disease | 3 | 2017 | 1031 | 0.140 |
Why?
| | Pacemaker, Artificial | 1 | 2020 | 126 | 0.140 |
Why?
| | Ultrasonography, Interventional | 1 | 2020 | 160 | 0.140 |
Why?
| | Nerve Growth Factor | 1 | 2018 | 34 | 0.140 |
Why?
| | Heart Arrest | 1 | 2022 | 407 | 0.140 |
Why?
| | Nervous System Diseases | 1 | 2021 | 284 | 0.140 |
Why?
| | Vena Cava, Inferior | 1 | 2019 | 81 | 0.140 |
Why?
| | Machine Learning | 1 | 2024 | 587 | 0.140 |
Why?
| | Heart Atria | 1 | 2019 | 144 | 0.140 |
Why?
| | Substance Abuse, Intravenous | 1 | 2019 | 128 | 0.140 |
Why?
| | Apoptosis | 2 | 2018 | 2430 | 0.130 |
Why?
| | Risk | 1 | 2020 | 911 | 0.130 |
Why?
| | Reactive Oxygen Species | 1 | 2020 | 621 | 0.130 |
Why?
| | Catheterization | 1 | 2018 | 183 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 286 | 0.130 |
Why?
| | Multidetector Computed Tomography | 1 | 2017 | 40 | 0.130 |
Why?
| | Terminally Ill | 1 | 2017 | 41 | 0.130 |
Why?
| | Tracheostomy | 1 | 2019 | 142 | 0.130 |
Why?
| | Nicorandil | 3 | 2021 | 11 | 0.130 |
Why?
| | Administration, Oral | 2 | 2018 | 848 | 0.130 |
Why?
| | Population Surveillance | 1 | 2020 | 485 | 0.130 |
Why?
| | Neuroprotection | 1 | 2017 | 46 | 0.130 |
Why?
| | STAT3 Transcription Factor | 1 | 2018 | 207 | 0.130 |
Why?
| | Prosthesis Design | 1 | 2019 | 357 | 0.120 |
Why?
| | Job Satisfaction | 2 | 2016 | 240 | 0.120 |
Why?
| | Regional Blood Flow | 2 | 2019 | 514 | 0.120 |
Why?
| | Mitral Valve Insufficiency | 1 | 2017 | 72 | 0.120 |
Why?
| | Defibrillators, Implantable | 1 | 2020 | 382 | 0.120 |
Why?
| | Coronary Vessels | 1 | 2018 | 251 | 0.120 |
Why?
| | Aneurysm, Infected | 1 | 2015 | 4 | 0.110 |
Why?
| | Lung Transplantation | 1 | 2019 | 338 | 0.110 |
Why?
| | Fibrosis | 1 | 2018 | 548 | 0.110 |
Why?
| | Respiration, Artificial | 1 | 2020 | 708 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 384 | 0.110 |
Why?
| | Smoking | 2 | 2019 | 1472 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 378 | 0.110 |
Why?
| | Thrombosis | 1 | 2019 | 393 | 0.110 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 583 | 0.110 |
Why?
| | Sensitivity and Specificity | 1 | 2020 | 1990 | 0.110 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 2118 | 0.100 |
Why?
| | Blood Vessel Prosthesis | 3 | 2022 | 140 | 0.100 |
Why?
| | Echocardiography | 1 | 2017 | 652 | 0.100 |
Why?
| | Renal Circulation | 1 | 2014 | 75 | 0.100 |
Why?
| | Clinical Competence | 3 | 2020 | 1244 | 0.100 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2017 | 392 | 0.100 |
Why?
| | Survival Analysis | 4 | 2019 | 1385 | 0.100 |
Why?
| | Mitochondria | 1 | 2020 | 984 | 0.100 |
Why?
| | Animals | 10 | 2025 | 38109 | 0.100 |
Why?
| | Disease Models, Animal | 5 | 2025 | 4569 | 0.100 |
Why?
| | Logistic Models | 2 | 2019 | 2119 | 0.100 |
Why?
| | Chi-Square Distribution | 1 | 2014 | 529 | 0.100 |
Why?
| | Biomarkers | 2 | 2025 | 4275 | 0.100 |
Why?
| | Cohort Studies | 5 | 2025 | 5965 | 0.090 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 923 | 0.090 |
Why?
| | RNA, Long Noncoding | 1 | 2014 | 178 | 0.090 |
Why?
| | Renal Insufficiency | 1 | 2014 | 169 | 0.090 |
Why?
| | Perception | 1 | 2015 | 377 | 0.090 |
Why?
| | Odds Ratio | 1 | 2014 | 1077 | 0.090 |
Why?
| | Body Mass Index | 1 | 2020 | 2438 | 0.090 |
Why?
| | Societies, Medical | 1 | 2016 | 887 | 0.090 |
Why?
| | Hypertension | 1 | 2020 | 1264 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 460 | 0.090 |
Why?
| | Chronic Disease | 1 | 2017 | 1813 | 0.080 |
Why?
| | Up-Regulation | 3 | 2018 | 852 | 0.080 |
Why?
| | Diabetes Mellitus | 1 | 2019 | 1098 | 0.080 |
Why?
| | Severity of Illness Index | 2 | 2016 | 2925 | 0.080 |
Why?
| | Nerve Tissue Proteins | 1 | 2014 | 592 | 0.080 |
Why?
| | Aged, 80 and over | 3 | 2025 | 8279 | 0.080 |
Why?
| | Learning | 1 | 2015 | 452 | 0.080 |
Why?
| | Analgesics, Opioid | 1 | 2019 | 1143 | 0.080 |
Why?
| | Renal Dialysis | 1 | 2014 | 462 | 0.080 |
Why?
| | Decision Making | 1 | 2017 | 980 | 0.080 |
Why?
| | Cells, Cultured | 1 | 2017 | 4155 | 0.080 |
Why?
| | Nuclear Proteins | 1 | 2014 | 749 | 0.070 |
Why?
| | Diverticulitis | 1 | 2009 | 8 | 0.070 |
Why?
| | Colostomy | 1 | 2009 | 28 | 0.070 |
Why?
| | Sigmoid Diseases | 1 | 2009 | 14 | 0.070 |
Why?
| | Intestinal Perforation | 1 | 2009 | 44 | 0.070 |
Why?
| | Colectomy | 1 | 2009 | 107 | 0.070 |
Why?
| | Kidney Transplantation | 1 | 2014 | 704 | 0.070 |
Why?
| | Melanoma | 1 | 2014 | 761 | 0.070 |
Why?
| | Brain | 1 | 2020 | 2941 | 0.070 |
Why?
| | Recovery of Function | 2 | 2025 | 710 | 0.070 |
Why?
| | Aortography | 2 | 2019 | 52 | 0.060 |
Why?
| | Operative Time | 2 | 2019 | 175 | 0.060 |
Why?
| | Young Adult | 3 | 2020 | 14126 | 0.060 |
Why?
| | Physicians | 1 | 2015 | 940 | 0.060 |
Why?
| | Sex Factors | 2 | 2026 | 2114 | 0.060 |
Why?
| | Laparoscopy | 1 | 2009 | 475 | 0.050 |
Why?
| | Cross-Sectional Studies | 1 | 2016 | 5872 | 0.050 |
Why?
| | Raffinose | 1 | 2023 | 29 | 0.050 |
Why?
| | Allopurinol | 1 | 2023 | 70 | 0.050 |
Why?
| | Cause of Death | 1 | 2026 | 472 | 0.050 |
Why?
| | Quality of Life | 1 | 2016 | 3192 | 0.050 |
Why?
| | Organ Preservation | 1 | 2023 | 130 | 0.050 |
Why?
| | Adenosine | 1 | 2023 | 255 | 0.040 |
Why?
| | Glutathione | 1 | 2023 | 375 | 0.040 |
Why?
| | Benzoates | 1 | 2021 | 50 | 0.040 |
Why?
| | Death | 1 | 2022 | 131 | 0.040 |
Why?
| | Monitoring, Intraoperative | 1 | 2021 | 64 | 0.040 |
Why?
| | Signal Transduction | 3 | 2020 | 5233 | 0.040 |
Why?
| | KATP Channels | 1 | 2021 | 17 | 0.040 |
Why?
| | Potassium Channels | 1 | 2021 | 145 | 0.040 |
Why?
| | United States Department of Veterans Affairs | 1 | 2025 | 768 | 0.040 |
Why?
| | Motor Activity | 1 | 2025 | 722 | 0.040 |
Why?
| | Imidazoles | 1 | 2021 | 254 | 0.040 |
Why?
| | Resource Allocation | 1 | 2020 | 53 | 0.040 |
Why?
| | Surgical Instruments | 1 | 2020 | 51 | 0.040 |
Why?
| | Collateral Circulation | 1 | 2019 | 19 | 0.040 |
Why?
| | Suture Techniques | 1 | 2020 | 131 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2021 | 498 | 0.040 |
Why?
| | Brachiocephalic Trunk | 1 | 2018 | 11 | 0.040 |
Why?
| | Axillary Artery | 1 | 2018 | 13 | 0.040 |
Why?
| | Glucose | 1 | 2023 | 1049 | 0.030 |
Why?
| | Time-to-Treatment | 1 | 2020 | 245 | 0.030 |
Why?
| | Echocardiography, Transesophageal | 1 | 2019 | 133 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 2019 | 248 | 0.030 |
Why?
| | Linear Models | 1 | 2020 | 854 | 0.030 |
Why?
| | Disease Progression | 2 | 2016 | 2852 | 0.030 |
Why?
| | Drug Synergism | 1 | 2018 | 357 | 0.030 |
Why?
| | Pakistan | 1 | 2017 | 78 | 0.030 |
Why?
| | Postoperative Care | 1 | 2019 | 288 | 0.030 |
Why?
| | Sternotomy | 1 | 2016 | 23 | 0.030 |
Why?
| | Vasodilator Agents | 1 | 2018 | 331 | 0.030 |
Why?
| | Nitric Oxide | 1 | 2021 | 897 | 0.030 |
Why?
| | Adolescent | 3 | 2023 | 22453 | 0.030 |
Why?
| | Thoracoscopy | 1 | 2016 | 62 | 0.030 |
Why?
| | Sodium | 1 | 2017 | 197 | 0.030 |
Why?
| | Myocardial Ischemia | 1 | 2018 | 285 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2019 | 1311 | 0.030 |
Why?
| | Professional Autonomy | 1 | 2016 | 32 | 0.030 |
Why?
| | Blotting, Western | 1 | 2018 | 1187 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2015 | 62 | 0.030 |
Why?
| | Patient Safety | 1 | 2019 | 349 | 0.030 |
Why?
| | Ohio | 1 | 2015 | 145 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2018 | 1371 | 0.030 |
Why?
| | Diacylglycerol O-Acyltransferase | 1 | 2014 | 5 | 0.030 |
Why?
| | Ventricular Function, Left | 1 | 2018 | 541 | 0.030 |
Why?
| | Phosphorylation | 1 | 2018 | 1733 | 0.030 |
Why?
| | Heart | 1 | 2018 | 636 | 0.030 |
Why?
| | Carnitine | 1 | 2014 | 90 | 0.030 |
Why?
| | Forecasting | 1 | 2015 | 391 | 0.020 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 359 | 0.020 |
Why?
| | Employment | 1 | 2015 | 188 | 0.020 |
Why?
| | Veterans | 1 | 2025 | 1603 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2014 | 509 | 0.020 |
Why?
| | RNA Interference | 1 | 2014 | 476 | 0.020 |
Why?
| | Insulin | 1 | 2023 | 2507 | 0.020 |
Why?
| | Triglycerides | 1 | 2014 | 521 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 635 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1695 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2014 | 528 | 0.020 |
Why?
| | Blood Pressure | 1 | 2017 | 1769 | 0.020 |
Why?
| | Surgical Staplers | 1 | 2009 | 5 | 0.020 |
Why?
| | Surgical Stomas | 1 | 2009 | 10 | 0.020 |
Why?
| | Fat Necrosis | 1 | 2009 | 10 | 0.020 |
Why?
| | Intraoperative Period | 1 | 2009 | 69 | 0.020 |
Why?
| | Blood Loss, Surgical | 1 | 2009 | 112 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2014 | 2499 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2014 | 3550 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2015 | 2738 | 0.010 |
Why?
| | Feasibility Studies | 1 | 2009 | 1095 | 0.010 |
Why?
|
|
Aftab's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|